Company profile for Serametrix Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Serametrix provides immune monitoring solutions for better understanding of monitoring immune responses to immunotherapies in clinical trial cancer patients. In partnership with the Ludwig Institute for Cancer Research (LICR) and other leading institutes Serametrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies. We standardize and prov...
Serametrix provides immune monitoring solutions for better understanding of monitoring immune responses to immunotherapies in clinical trial cancer patients. In partnership with the Ludwig Institute for Cancer Research (LICR) and other leading institutes Serametrix has developed a suite of immunoassays that monitor anti-tumor immunity in patients enrolled into clinical trials for novel cancer therapies. We standardize and provide access to proven technologies from trusted leaders in the field of immuno oncology. As a commercial entity we excel in combining technical expertise with practical deliverability to move the clinical development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2235 Farraday Ave,Suite N, Carlsbad, CA, 92008
Telephone
Telephone
+1-760-652-4060
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.serametrix.com/infinity-study/

PRESS RELEASE
22 May 2019
Caprion Acquires Serametrix Corp.
Caprion Acquires Serametrix Corp.

30 Apr 2019

// PR NEWSWIRE

https://www.prnewswire.com/news-releases/caprion-biosciences-expands-its-global-biomarker-and-immune-monitoring-franchise-by-acquiring-serametrix-corporation-300840307.html

PR NEWSWIRE
30 Apr 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty